Therefore, the viability of colon cancer cells declined when treated with zinc protoporphyrin, an inhibitor of HO-1, indicating that HO-1 is a valuable biomarker for anti-colon cancer therapy 201. This evidence concerns the gene HMOX1 and malignant colon neoplasm.